CEP78 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.514600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.170600E-01
Normal-vs-Stage2
3.485200E-01
Normal-vs-Stage3
8.776400E-02
Normal-vs-Stage4
3.796200E-01
Stage1-vs-Stage2
8.200800E-01
Stage1-vs-Stage3
1.536440E-01
Stage1-vs-Stage4
7.767400E-01
Stage2-vs-Stage3
5.075800E-02
Stage2-vs-Stage4
5.317600E-01
Stage3-vs-Stage4
1.385810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.578000E-01
Normal-vs-AfricanAmerican
1.077800E-01
Normal-vs-Asian
5.934200E-02
Caucasian-vs-AfricanAmerican
5.697800E-01
Caucasian-vs-Asian
5.872400E-01
AfricanAmerican-vs-Asian
8.773800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.335200E-01
Normal-vs-Female
3.799000E-01
Male-vs-Female
2.375600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.377000E-01
Normal-vs-Age(41-60Yrs)
4.572400E-01
Normal-vs-Age(61-80Yrs)
3.118400E-01
Normal-vs-Age(81-100Yrs)
3.604000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.066000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.383200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.098600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.719630E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.928400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.470000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.911000E-01
Normal-vs-Daily Drinker
2.919600E-01
Normal-vs-Weekly Drinker
1.044830E-01
Normal-vs-Occasional Drinker
3.132800E-01
Normal-vs-Social Drinker
2.725200E-01
Non Drinker-vs-Daily Drinker
9.726000E-01
Non Drinker-vs-Weekly Drinker
2.733600E-01
Non Drinker-vs-Occasional Drinker
7.080200E-01
Non Drinker-vs-Social Drinker
2.908100E-02
Daily Drinker-vs-Weekly Drinker
2.533600E-01
Daily Drinker-vs-Occasional Drinker
7.048000E-01
Daily Drinker-vs-Social Drinker
4.947500E-02
Weekly Drinker-vs-Occasional Drinker
4.561800E-01
Weekly Drinker-vs-Social Drinker
3.679400E-01
Occasional Drinker-vs-Social Drinker
8.161600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.835000E-01
Normal-vs-Grade 2
9.834000E-01
Normal-vs-Grade 3
9.870600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.342000E-01
Grade 1-vs-Grade 3
6.903800E-01
Grade 1-vs-Grade 4
9.835000E-01
Grade 2-vs-Grade 3
9.361000E-01
Grade 2-vs-Grade 4
9.834000E-01
Grade 3-vs-Grade 4
9.870600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.992400E-01
Normal-vs-NonDiabetic
3.509000E-01
Diabetic-vs-NonDiabetic
2.170400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.214200E-01
Normal-vs-NoPancreatitis
3.405000E-01
Pancreatitis-vs-NoPancreatitis
6.273600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.509900E-02
Normal-vs-N1
3.472200E-01
N0-vs-N1
6.885200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.908400E-01
Normal-vs-TP53-NonMutant
3.978800E-01
TP53-Mutant-vs-TP53-NonMutant
9.141400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
